Glen Clova Scientific
1 known investors
Glenclova Scientific develops therapeutic vaccines that enable patients to generate natural antibodies against disease targets, positioned as an alternative to conventional biologics like monoclonal antibodies. The company focuses on treating chronic diseases and expanding affordable access to biologic therapies for underserved patient populations.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Glen Clova Scientific do?
- Glenclova Scientific develops therapeutic vaccines that enable patients to generate natural antibodies against disease targets, positioned as an alternative to conventional biologics like monoclonal antibodies. The company focuses on treating chronic diseases and expanding affordable access to biologic therapies for underserved patient populations.
- Who are Glen Clova Scientific's investors?
- Glen Clova Scientific's investors include DSW Ventures.